BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25963701)

  • 21. A case of esophageal cancer with multiple lymph node metastases which responded to neoadjuvant chemotherapy (DCF therapy).
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Yamaguchi K; Murayama M; Konno S; Katsube T; Ogawa K; Ide H
    Anticancer Res; 2010 Jan; 30(1):221-6. PubMed ID: 20150639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A Case of Neuroendocrine Carcinoma of the Esophagus Treated with Neoadjuvant Chemotherapy Comprising 5-Fluorouracil plus Cisplatin].
    Muroya T; Wajima N; Akasaka H; Hasebe T; Yakoshi Y; Yachi T; Akaishi T; Sato K; Mitsuhashi Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2184-2186. PubMed ID: 28133263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of pathologically complete response of esophageal carcinoma treated with low-dose 5-FU/CDDP as neoadjuvant chemotherapy].
    Kobayashi M; Kishi M; Taniguchi F; Kuwata K; Watanabe N; Kimura K; Kokudo Y; Muraoka A; Tatemoto A; Tsumura M
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1715-8. PubMed ID: 23152026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma.
    Akiyama Y; Iwaya T; Endo F; Chiba T; Takahara T; Otsuka K; Nitta H; Koeda K; Mizuno M; Kimura Y; Sasaki A
    Surg Endosc; 2018 Jan; 32(1):391-399. PubMed ID: 28664431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neoadjuvant chemoradiotherapy for advanced squamous cell carcinoma of thoracic esophagus].
    Takahashi S; Sato Y; Kondo M; Kudo T; Shimokuni T; Maeda Y; Honnma S; Shinohara T; Kohashi S; Todo S
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):45-9. PubMed ID: 14750320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
    Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined radiotherapy and pre-radiation chemotherapy with cisplatin and 5-fluorouracil for advanced esophageal carcinoma. II. Clinical evaluation in cases with higher than T2 stage].
    Sueyama H
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1608-18. PubMed ID: 2230444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of the positive circumferential resection margin in pathologic T3 squamous cell carcinoma of the esophagus with or without neoadjuvant chemotherapy.
    Okada N; Fujii S; Fujita T; Kanamori J; Kojima T; Hayashi R; Daiko H
    Surgery; 2016 Feb; 159(2):441-50. PubMed ID: 26391150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis.
    Nomura M; Oze I; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Kawai R; Uemura N; Ishihara M; Tanaka T; Tajika M; Niwa Y; Muro K; Muto M
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):357-63. PubMed ID: 26092324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of T4 esophageal squamous cell carcinoma in esophagogastric junction effectively treated by neoadjuvant FAP therapy].
    Maruyama K; Nagai K; Naoi Y; Yokoyama S; Yoneda K; Katsumoto Y; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2005 May; 32(5):659-62. PubMed ID: 15918567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].
    Matsutani T; Yoshida H; Sasajima K; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Takao Y; Umakoshi M; Hayakawa T; Katayama H; Hosone M; Uchida E
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):645-8. PubMed ID: 22504694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical resection with and without chemotherapy in oesophageal cancer.
    Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
    Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
    [No Abstract]   [Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma.
    Ohwada S; Nakamura S; Izumi M; Kawashima Y; Ogawa T; Kobayashi I; Hosomura Y; Joshita T; Lino Y; Morishita Y
    Jpn J Clin Oncol; 1995 Jun; 25(3):79-85. PubMed ID: 7596052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV].
    Bando K; Onda M; Miyashita M; Takahashi Y; Takita M; Matsutani T; Okawa K; Sasajima K; Ujihara Y; Takubo K; Yamashita K
    Gan To Kagaku Ryoho; 1998 May; 25(6):915-8. PubMed ID: 9617331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical resection with and without chemotherapy in oesophageal cancer.
    Maraveyas A; O'Boyle C; Cowen M
    Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
    [No Abstract]   [Full Text] [Related]  

  • 39. [Resection of esophageal cancer infiltrating the left main bronchus following complete response to preoperative radiochemotherapy--a case report].
    Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1949-53. PubMed ID: 14650965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Murayama M; Konno S; Yoshimatsu K; Shiozawa S; Katsube T; Ogawa K
    Anticancer Res; 2008; 28(4C):2321-6. PubMed ID: 18751413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.